23May/13

European Medicines Agency Validates Gilead's Marketing Application for … – Business Wire (press release)

European Medicines Agency Validates Gilead’s Marketing Application for
Business Wire (press release)
Chronic HCV is a major cause of liver cancer and liver transplantation in Europe and around the world. The current standard of care for HCV involves 24-48 weeks of therapy with RBV and peg-IFN, which has to be injected and is associated with

and more »

23May/13

BioVentrix to Exhibit Revivent™ System, which Surpasses Survival Benefit … – Business Wire (press release)

BioVentrix to Exhibit Revivent™ System, which Surpasses Survival Benefit
Business Wire (press release)
LISBON, Portugal–(BUSINESS WIRE)–BioVentrix, pioneer of the Less Invasive Ventricular Enhancement™ (LIVE™) procedure for the treatment of heart failure (HF), announced today that it will showcase its Revivent™ Myocardial Anchoring System at the

and more »